In Vitro Diagnostics (IVD) provide critical information about the physiological and pathological state of body for effective health and drug/therapy monitoring. In 2011, North America and Europe occupied majority share of the in vitro diagnostics market due to the high healthcare expenditure and structured association of clinical laboratories. On the other hand, market players in the in vitro diagnostics market are keen to accelerate their growth by capitalizing on unmet opportunities present in the emerging economies. Although clinical chemistry IVDs led the market in 2011 across the US, India, and China market, the growth in the molecular diagnostics segment is forecasted owing to their efficacy in the early detection of the disease.
Increasing ageing population and rising cases of infectious diseases and chronic diseases – such as cardiovascular diseases, diabetes, cancer, and sexually transmitted diseases – are significant growth drivers of this market. Besides this, escalating health expenditure and increasing demand for advanced and automated diagnostics technologies are likely to drive the in vitro diagnostics market. However, on the other hand, reimbursement issues and the existence of ambiguity in the regulatory environment are restraints for this market. Despite this, the emerging molecular diagnostics and epigenomics-based diagnostics segments are expected to provide considerable growth opportunities in this market. Even, collaborations among diagnostic and pharmaceutical companies for research and development will help this market grow in the near future.
The global in vitro diagnostics market is segmented into markets by technique, product type, application, end users, and geography. The global in vitro diagnostics market by technique is segmented as immunoassay/immunochemistry, clinical chemistry, hematology, coagulation, microbiology, molecular diagnostics and other clinical instruments. The global in vitro diagnostics market in terms of product type is classified into instruments, reagents, data management system hardware/software, and services. In context to end users, the market segments for the stated market include hospitals, laboratory, academics, point-of-care testing, and others. On the basis of geography, the global in vitro diagnostics market is divided into North America, Europe, Latin America, Asia Pacific and RoW. The leading companies included are Bayer AG, Abbott Laboratories, Beckham Coulter Inc., Johnson & Johnson, Alere Inc, Siemens Healthcare, Biomerieux SA, and Danaher Corporation. Product launches, collaborations, and mergers and acquisitions are major strategies of these companies. For instance, Alere Inc. recently announced acquisition of Epocal Inc., a provider of technologies that support blood gas and electrolyte testing at the point of care.
To Read the Report Kindly Visit: http://www.alliedmarketresearch.com/in-vitro-diagnostic-ivd-market
Market attractiveness analysis, compares various techniques, products, end users and applications within their respective markets along with factors responsible for the most attractive market. Market attractiveness analysis for the most attractive geographical region worldwide is also considered and has detailed study of factors responsible for rapid growth in the regions. Various economic factors which are significant in determining market trend, buying decisions and market attractiveness had been analyzed for market estimation and forecasting. Detailed elaboration of drivers, restraints and opportunities in the report will enable in strategic decision making with perceptive to identify potential market. In addition to this, the study also discusses various environmental and regulatory factors critical for the market growth. Thus, estimation of market numbers, with due consideration to all these factors has helped in enhancing the scope of the report. This analysis will support stakeholders such as manufacturers and distributers in identifying and capturing markets with high potential. Historical data is provided for 2011, 2012 whereas forecast is available through 2020 in terms of revenue (USD million) for each and every segments.
For More Information Kindly Contact :
5320 SW Macadam Avenue,
Suite 100, Portland, OR 97239
Direct: +1 (617) 674-4143
Toll Free: +1 (855) 711-1555 (U.S. & Canada)
Fax: +1 (855) 550-5975